This paper provides local data on the provision of services for patients diagnosed with ovarian cancer in 1996 prior to the reorganisation of cancer services. It documents a service for 140 patients provided by 80 consultant teams and illustrates the need for reorganisation to meet the evidence base already in existence for improvement in survival and will serve as a baseline for future audits in this area.
INTRODUCTION
Driven by some of the worst survival rates in Western Europe' there has been widespread reorganisation in recent years of the way cancer services in the UK are delivered.2 Given the need to improve service quality and to justify the massive resource commitment required, monitoring and evaluation ofthe changes in terms of care processes and outcomes are clearly required. These may be measured using the patient care pathway. We report here an example relating to ovarian cancer. In 1996 the Campbell report3 made wide-ranging recommendations for change in the way cancer services were organised in Northern Ireland. Broadly in line with those made by the Recommendations specific to ovarian cancer were the use of ultrasound scanning and measurement of blood tumour marker levels as part of the assessment process, and the development of regionally agreed management guidelines to be used within a network of care. The latest regional guidance determines that treatment should only take place in the cancer centre or in a cancer unit and only under the care of a lead clinician in gynaecological oncology. Iftreatment is proposed to take place in a cancer unit the patient's management plan should be agreed with the multidisciplinary team at the cancer centre.4 Observational studies of patients with ovarian cancer lend broad support to these recommendations. The involvement of a gynaecologist at both presentation and treatment, and further management by a multidisciplinary team have been shown to improve survival.5 6'7 Operation by specialist gynaecologists has also been found to improve survival among women with stage III disease.8 However, the case for ensuring operators treat an optimum volume of patients is unproven to date.7 Part of a larger study of the overall cancer service changes in Northern Ireland, this paper aims to provide a baseline description of the care received by women diagnosed in 1996 with ovarian cancer, prior to anticipated service change.
METHODS
All ovarian cancer notifications for 1996 were extracted from the Northern Ireland Cancer Registry. This included both fully malignant and borderline malignant tumours, in accordance with the ICD-0-2 classification.9 A retrospective review ofrecords was undertaken by one trained researcher (RM). For inclusion in the study each case was required to have at least one ofthe following: hospital case notes; General Practitioner records or histopathology reports. In addition to the basic demographic information, details of presenting symptoms, the referral and assessment processes, diagnostic procedures, tumour information, treatment details, and outcomes were collected. Information was recorded on a Microsoft Access database and analysed using SPSS software. This work was carried out in a population-based cancer registry. Cancer registries are ideally placed to assist in the key public health function of service evaluation. Working in established partnerships with numerous reporting agencies they have considerable expertise in the collection, collation, analysis and dissemination of population-based data within a data protection framework. The main limitation of the study lies in the fact that it was carried out some three to four years after the majority of patient treatment had occurred. Underreporting of the true picture can be a problem in any retrospective study, but is compounded in this case by our inability to differentiate between data genuinely "not recorded" and that missing because ofunavailable casenotes, as we did not record which data sources were accessed for each case. In addition, there is the impression that notes tended to be unavailable for deceased patients as opposed to survivors. This missing data may therefore be more representative of women with advanced disease at presentation.
CONCLUSION
This population-based study documents both the process and outcomes of care for women diagnosed with ovarian cancer in Northern Ireland in 1996. The findings suggest a picture of service provision very different from that later recommended by the Campbell Report, yet similar to that seen elsewhere in the UK at that time. A study of cases incident in 2001 is now underway to close the audit loop.
